1. Home
  2. BCYC vs ARKO Comparison

BCYC vs ARKO Comparison

Compare BCYC & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • ARKO
  • Stock Information
  • Founded
  • BCYC 2009
  • ARKO 1970
  • Country
  • BCYC United Kingdom
  • ARKO United States
  • Employees
  • BCYC N/A
  • ARKO N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • ARKO Oil Refining/Marketing
  • Sector
  • BCYC Health Care
  • ARKO Energy
  • Exchange
  • BCYC Nasdaq
  • ARKO Nasdaq
  • Market Cap
  • BCYC 566.5M
  • ARKO 501.4M
  • IPO Year
  • BCYC 2019
  • ARKO N/A
  • Fundamental
  • Price
  • BCYC $8.70
  • ARKO $4.66
  • Analyst Decision
  • BCYC Buy
  • ARKO Buy
  • Analyst Count
  • BCYC 11
  • ARKO 4
  • Target Price
  • BCYC $25.00
  • ARKO $7.19
  • AVG Volume (30 Days)
  • BCYC 308.3K
  • ARKO 375.9K
  • Earning Date
  • BCYC 08-05-2025
  • ARKO 08-06-2025
  • Dividend Yield
  • BCYC N/A
  • ARKO 2.59%
  • EPS Growth
  • BCYC N/A
  • ARKO N/A
  • EPS
  • BCYC N/A
  • ARKO 0.03
  • Revenue
  • BCYC $25,722,000.00
  • ARKO $8,488,413,000.00
  • Revenue This Year
  • BCYC $7.35
  • ARKO N/A
  • Revenue Next Year
  • BCYC N/A
  • ARKO N/A
  • P/E Ratio
  • BCYC N/A
  • ARKO $178.13
  • Revenue Growth
  • BCYC N/A
  • ARKO N/A
  • 52 Week Low
  • BCYC $6.10
  • ARKO $3.51
  • 52 Week High
  • BCYC $28.67
  • ARKO $7.84
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 61.54
  • ARKO 56.65
  • Support Level
  • BCYC $8.21
  • ARKO $4.53
  • Resistance Level
  • BCYC $9.18
  • ARKO $4.73
  • Average True Range (ATR)
  • BCYC 0.50
  • ARKO 0.15
  • MACD
  • BCYC 0.12
  • ARKO 0.02
  • Stochastic Oscillator
  • BCYC 76.81
  • ARKO 85.11

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

Share on Social Networks: